Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.26 is 13% above its 5-year average of 4.66, around the middle of its 5-year range (3.18–7.74).
As of the fiscal period ended Tuesday, June 30, 2026. 20.18% above its 12-month average of 4.38.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.26.
CURRENT RATIO
5.26
CURRENT RATIO AVG TTM
4.38
CURRENT RATIO AVG 3Y
3.56
CURRENT RATIO AVG 5Y
4.66
CURRENT RATIO AVG 10Y
4.92
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+20.18%
CURRENT VS 3Y AVG
+47.87%
CURRENT VS 5Y AVG
+12.77%
CURRENT VS 10Y AVG
+6.95%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.67
median of 830 covered companies
CURRENT VS SECTOR MEDIAN
+43.13%
vs the sector median at left
Market Cap
$204.66M
Current Ratio
20.05
TTM Avg
17.55
3Y Avg
12.54
5Y Avg
12.54
Market Cap
$205.69M
Current Ratio
7.48
TTM Avg
9.04
3Y Avg
6.33
5Y Avg
4.86
Market Cap
$205.75M
Current Ratio
10.89
TTM Avg
11.84
3Y Avg
8.89
5Y Avg
15.32
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $203.26M | 5.26 | 4.38 | 3.56 | 4.66 |
| Sionna Therapeutics, Inc. (SION)vs › | $204.66M | 20.05 | 17.55 | 12.54 | 12.54 |
| Pro-Dex, Inc. (PDEX)vs › | $205.17M | 4.10 | 3.67 | 3.34 | 3.14 |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $205.69M | 7.48 | 9.04 | 6.33 | 4.86 |
| Entrada Therapeutics, Inc. (TRDA)vs › | $205.75M | 10.89 | 11.84 | 8.89 | 15.32 |
| Electra Therapeutics Inc. (ETRA)vs › | $206.12M | N/A | N/A | N/A | N/A |
| Exagen Inc. (XGN)vs › | $199.53M | 3.18 | 3.08 | 4.43 | 6.31 |
| Surrozen, Inc. (SRZN)vs › | $197.81M | 12.14 | 7.27 | 7.16 | 7.21 |
| Compugen Ltd. (CGEN)vs › | $209.91M | 5.72 | 5.91 | 5.85 | 7.15 |
| Prelude Therapeutics Incorporated (PRLD)vs › | $210.65M | 4.07 | 3.65 | 6.88 | 10.38 |
Current Ratio
5.26
Quick Ratio
5.26
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.26 |
| 2026-03-31 | 5.25 |
| 2025-12-31 | 3.83 |
| 2025-09-30 | 3.76 |
| 2025-06-30 | 3.78 |
| 2025-03-31 | 3.34 |
| 2024-12-31 | 3.40 |
| 2024-09-30 | 3.29 |
| 2024-06-30 | 3.52 |
| 2024-03-31 | 3.53 |
| 2023-12-31 | 3.18 |
| 2023-09-30 | 3.95 |
| 2023-06-30 | 4.90 |
| 2023-03-31 | 6.91 |
| 2022-12-31 | 7.74 |
| 2022-09-30 | 4.82 |
| 2022-06-30 | 5.54 |
| 2022-03-31 | 6.24 |
| 2021-12-31 | 5.37 |
| 2021-09-30 | 5.93 |
| 2021-06-30 | 4.43 |
| 2021-03-31 | 5.85 |
| 2020-12-31 | 6.19 |
| 2020-09-30 | 6.61 |
| 2020-06-30 | 7.75 |
| 2020-03-31 | 7.75 |
| 2019-12-31 | 5.77 |
| 2019-09-30 | 6.56 |
| 2019-06-30 | 6.18 |
| 2019-03-31 | 7.92 |
| 2018-12-31 | 22.48 |
| 2018-09-30 | 7.62 |
| 2018-06-30 | 7.32 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 8.50 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
